Genomic Sequencing in Clinical TrialsIn this article, researchers from Northwestern University Feinberg review the current and future directions of clinical research with respect to genomic sequencing.
Foundation Medicine and Dana-Farber Cancer Institute Identify Novel Genomic Alterations in Lung and Colorectal CancerFindings highlight clinical application of next-generation sequencing to suggest targeted therapeutic options for patients.
Transformational Fruit Fly Genome Catalog CompletedScientists now have a reference manual that should speed gene discoveries in everything from pest control to personalized medicine.
Animal Cell Therapies Announces Cell Inventory Value at $6 MillionThe evaluation demonstrates the importance of this first step in the company's mission to improve and extend the lives of dogs through innovative stem cell products and services.
Diffusion Pharmaceuticals Begins Clinical Trial for Treatment of Primary Brain CancerCompany announced clinical trial testing of its lead drug candidate trans sodium crocetinate (TSC) as a first-line treatment for newly diagnosed primary brain cancer, also known as glioblastoma or GBM.
Drug Halts Organ Damage in Inflammatory Genetic DisorderNIH study shows benefits of long-term Kineret therapy in people with NOMID.
Syndax Pharmaceuticals Announces Entinostat Enhanced Activity of Cancer ImmunotherapiesData highlights novel immunomodulatory effects of entinostat in renal and prostate cancer models.
Hunting Could Hurt Genetic Diversity of Sandhill Cranes, UW Research SuggestsResearch uses DNA fingerprinting to assess the genetic makeup of cranes.
Results From Phase I Clinical Trials Demonstrate Positive Safety Data of AVI BioPharma's RNA-Based TherapeuticsAVI BioPharma, Inc. have announced positive safety results from all six dose cohorts in the single ascending dose studies of AVI-6002 and AVI-6003, AVI's lead drug candidates being evaluated for the treatment of Ebola virus and Marburg virus, respectively.
Compugen Cancer Target Results Demonstrate Significant Potential for Cancer ImmunotherapyFindings support CGEN-15001T's potential as a powerful drug target for cancer immunotherapy.
